Aaron Kimson
Stock Analyst at Citizens JMP
(3.40)
# 2,417
Out of 4,707 analysts
95
Total ratings
54.9%
Success rate
6.1%
Average return
Main Sectors:
Stocks Rated by Aaron Kimson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NCNO nCino | Maintained: Buy | $23 → $25 | $22.14 | +12.92% | 17 | Aug 26, 2026 | |
| EXFY Expensify | Upgraded: Buy | $3 | $2.37 | +26.58% | 13 | Aug 7, 2026 | |
| HNGE Hinge Health | Maintained: Buy | $96 → $107 | $92.69 | +15.44% | 5 | Aug 5, 2026 | |
| PBI Pitney Bowes | Maintained: Buy | $19 → $22 | $16.99 | +29.49% | 5 | Jul 31, 2026 | |
| GWRE Guidewire Software | Maintained: Buy | $300 → $220 | $149.71 | +46.95% | 14 | Jun 5, 2026 | |
| BLND Blend Labs | Maintained: Buy | $5 → $4 | $1.49 | +168.46% | 9 | May 8, 2026 | |
| PCOR Procore Technologies | Upgraded: Buy | $71 | $56.18 | +26.38% | 15 | Apr 29, 2026 | |
| PHR Phreesia | Downgraded: Hold | n/a | $10.22 | - | 10 | Apr 1, 2026 | |
| EQPT EquipmentShare.com | Initiated Coverage: Buy | $42 | $19.40 | +116.49% | 1 | Feb 17, 2026 | |
| EVCM EverCommerce | Reiterated: Buy | $15 | $7.18 | n/a | 6 | May 12, 2025 |
nCino
Aug 26, 2026
Maintained: Buy
Price Target: $23 → $25
Current: $22.14
Upside: +12.92%
Expensify
Aug 7, 2026
Upgraded: Buy
Price Target: $3
Current: $2.37
Upside: +26.58%
Hinge Health
Aug 5, 2026
Maintained: Buy
Price Target: $96 → $107
Current: $92.69
Upside: +15.44%
Pitney Bowes
Jul 31, 2026
Maintained: Buy
Price Target: $19 → $22
Current: $16.99
Upside: +29.49%
Guidewire Software
Jun 5, 2026
Maintained: Buy
Price Target: $300 → $220
Current: $149.71
Upside: +46.95%
Blend Labs
May 8, 2026
Maintained: Buy
Price Target: $5 → $4
Current: $1.49
Upside: +168.46%
Procore Technologies
Apr 29, 2026
Upgraded: Buy
Price Target: $71
Current: $56.18
Upside: +26.38%
Phreesia
Apr 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $10.22
Upside: -
EquipmentShare.com
Feb 17, 2026
Initiated Coverage: Buy
Price Target: $42
Current: $19.40
Upside: +116.49%
EverCommerce
May 12, 2025
Reiterated: Buy
Price Target: $15
Current: $7.18
Upside: n/a